{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:41:03Z","timestamp":1789094463675,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100007488","name":"Indian Institute of Technology Delhi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007488","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011067","name":"Indian Institute of Technology Mandi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011067","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.pharma.2024.12.002","type":"journal-article","created":{"date-parts":[[2024,12,10]],"date-time":"2024-12-10T18:59:57Z","timestamp":1733857197000},"page":"493-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Amorolfine hydrochloride loaded solid lipid nanoparticles: Preparation, characterization and ex vivo nail permeation study to treat onychomycosis"],"prefix":"10.1016","volume":"83","author":[{"given":"Tasleem","family":"Ahmed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nithya","family":"Shanthi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun Kumar","family":"Mahato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharma.2024.12.002_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0229414","article-title":"Assessment of the nail penetration of antifungal agents, with different physicochemical properties","volume":"15","author":"Davies-Strickleton","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pharma.2024.12.002_bib0210","first-page":"1","article-title":"Onychomycosis: an updated review","volume":"14","author":"Leung","year":"2020","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/j.pharma.2024.12.002_bib0215","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40257-019-00448-4","article-title":"Onychomycosis in athletes","volume":"20","author":"Daggett","year":"2019","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.pharma.2024.12.002_bib0220","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/2211738507666190228104031","article-title":"Novel drug delivery strategies for the treatment of onychomycosis","volume":"7","author":"Dhamoon","year":"2019","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.pharma.2024.12.002_bib0225","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2165\/00003495-199549010-00008","article-title":"Amorolfine: a review of its pharmacological properties and therapeutic potential in the treatment of onychomycosis and other superficial fungal infections","volume":"49","author":"Haria","year":"1995","journal-title":"Drugs"},{"key":"10.1016\/j.pharma.2024.12.002_bib0230","unstructured":"Loceryl 5% w\/v Medicated Nail Lacquer n.d.:2-7. https:\/\/www.medicines.org.uk\/emc\/product\/1411\/smpc#gref."},{"key":"10.1016\/j.pharma.2024.12.002_bib0235","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ma12071028","article-title":"Potential of chemical and physical enhancers for transungual delivery of amorolfine hydrochloride","volume":"12","author":"\u0160veikauskait\u0117","year":"2019","journal-title":"Materials (Basel)"},{"key":"10.1016\/j.pharma.2024.12.002_bib0240","doi-asserted-by":"crossref","first-page":"24","DOI":"10.2174\/2211738507666190228104031","article-title":"Novel drug delivery strategies for the treatment of onychomy- cosis","volume":"7","author":"Dhamoon","year":"2019","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.pharma.2024.12.002_bib0245","doi-asserted-by":"crossref","first-page":"639","DOI":"10.4155\/tde-2016-0040","article-title":"Solid lipid nanoparticles for antifungal drugs delivery for topical applications Therapeutic Delivery Systemic","volume":"7","author":"Cassano","year":"2016","journal-title":"Ther Deliv"},{"key":"10.1016\/j.pharma.2024.12.002_bib0250","first-page":"1","article-title":"Voriconazole-loaded nanostructured lipid carriers (NLC) for drug delivery in deeper regions of the nail plate","volume":"531","author":"Amaral","year":"2017","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0255","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s40005-013-0087-y","article-title":"Solid lipid nanoparticles (SLNs) and nanostructured lipid carriers (NLCs): recent advances in drug delivery","volume":"43","author":"Yoon","year":"2013","journal-title":"Journal of Pharmaceutical Investigation"},{"key":"10.1016\/j.pharma.2024.12.002_bib0260","doi-asserted-by":"crossref","first-page":"2487","DOI":"10.3390\/pharmaceutics14112487","article-title":"Topical semisolid products \u2013 understanding the impact of metamorphosis on skin penetration and physicochemical properties","volume":"14","author":"Jin","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.pharma.2024.12.002_bib0265","first-page":"12","article-title":"Onychomycosis: potential of nail lacquers in transungual delivery of anti-fungals","volume":"2016","author":"Akhtar","year":"2016","journal-title":"Scientifica (Cairo)"},{"key":"10.1016\/j.pharma.2024.12.002_bib0270","doi-asserted-by":"crossref","first-page":"103808","DOI":"10.1016\/j.jddst.2022.103808","article-title":"Oral delivery of butoconazole nitrate nanoparticles for systemic treatment of chronic paracoccidioidomycosis: a future aspect","volume":"77","author":"Ahmed","year":"2022","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.12.002_bib0275","first-page":"562","article-title":"Development and evaluation of a novel transungual formulation (nail patch) for the treatment of onychomycosis","volume":"3","author":"Metta","year":"2018","journal-title":"International Journal of Innovative Science and Research Technology"},{"key":"10.1016\/j.pharma.2024.12.002_bib0280","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.2217\/nnm-2017-0052","article-title":"Development of anti-fungal therapies using nanomaterials","volume":"15","author":"Niemirowicz","year":"2017","journal-title":"Nanomedicine"},{"key":"10.1016\/j.pharma.2024.12.002_bib0285","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1208\/s12249-009-9199-0","article-title":"Preparation and evaluation of miconazole nitrate-loaded solid lipid nanoparticles for topical delivery","volume":"10","author":"Bhalekar","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2024.12.002_bib0290","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1211\/0022357044959","article-title":"Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs","volume":"56","author":"Hu","year":"2004","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"10.1016\/j.pharma.2024.12.002_bib0295","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.2147\/IJN.S82558","article-title":"Multifaceted applications of bile salts in pharmacy: an emphasis on nanomedicine","volume":"10","author":"Elnaggar","year":"2015","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.pharma.2024.12.002_bib0300","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01688","article-title":"Preparation of luliconazole nanocrystals loaded hydrogel for improvement of dissolution and antifungal activity","volume":"5","author":"Kumar","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/j.pharma.2024.12.002_bib0305","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ijpharm.2015.07.020","article-title":"UV-curable gel formulations: potential drug carriers for the topical treatment of nail diseases","volume":"492","author":"Kerai","year":"2015","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0310","series-title":"A kind of determination method of amorolfine hydrochloride and its interfering substance","author":"Ziping","year":"2020"},{"key":"10.1016\/j.pharma.2024.12.002_bib0315","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ijpharm.2013.02.027","article-title":"Solid lipid nanoparticle preparation by a warm microemulsion based process: influence of microemulsion microstructure","volume":"446","author":"Fadda","year":"2013","journal-title":"Int J Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0320","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.3109\/10717544.2014.932862","article-title":"Preparation, characterization and in vitro activities evaluation of solid lipid nanoparticles based on PEG-40 stearate for antifungal drugs vaginal delivery","volume":"23","author":"Cassano","year":"2016","journal-title":"Drug Deliv"},{"key":"10.1016\/j.pharma.2024.12.002_bib0325","first-page":"1","article-title":"Formulation and optimization of topical solid lipid nanoparticles based gel of dapsone using design of experiment","volume":"6","author":"Deshkar","year":"2018","journal-title":"Pharm Nanotechnol"},{"key":"10.1016\/j.pharma.2024.12.002_bib0330","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.3109\/03639045.2014.956111","article-title":"Development of dry powder inhaler formulation loaded with alendronate solid lipid nanoparticles: Solid-state characterization and aerosol dispersion performance","volume":"41","author":"Dolatabadi","year":"2015","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0335","first-page":"853","article-title":"Preparation of dry powder inhaler of montelukast sodium- loaded solid lipid nanoparticles and evaluation of its physicochemical characteristics","volume":"35","author":"Rahmanian","year":"2016","journal-title":"Lat Am J Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0340","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jddst.2018.05.017","article-title":"Formulation, characterization and cytotoxicity evaluation of ketotifen-loaded nanostructured lipid carriers","volume":"46","author":"Ezzati Nazhad Dolatabadi","year":"2018","journal-title":"J Drug Deliv Sci Technol"},{"key":"10.1016\/j.pharma.2024.12.002_bib0345","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1208\/s12249-019-1334-y","article-title":"Ethambutol-loaded solid lipid nanoparticles as dry powder inhalable formulation for tuberculosis therapy","volume":"20","author":"Nemati","year":"2019","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2024.12.002_bib0350","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s42452-024-05897-z","article-title":"Solid lipid nanocarriers for drug delivery: design innovations and characterization strategies \u2013 a comprehensive review","volume":"6","author":"Bukke","year":"2024","journal-title":"Discov Appl Sci"},{"key":"10.1016\/j.pharma.2024.12.002_bib0355","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/molecules28227508","article-title":"Sulconazole-loaded solid lipid nanoparticles for enhanced antifungal activity: in vitro and in vivo approach","volume":"28","author":"Samee","year":"2023","journal-title":"Molecules"},{"key":"10.1016\/j.pharma.2024.12.002_bib0360","doi-asserted-by":"crossref","first-page":"611","DOI":"10.2147\/IJN.S16815","article-title":"Novel formulation and evaluation of a Q10-loaded solid lipid nanoparticle cream: in vitro and in vivo studies","volume":"6","author":"Farboud","year":"2011","journal-title":"Int J Nanomedicine"},{"key":"10.1016\/j.pharma.2024.12.002_bib0365","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/0021-9797(90)90390-A","article-title":"Three-phase behavior and HLB numbers of bile salts and lecithin in a water-oil system","volume":"136","author":"Kunieda","year":"1990","journal-title":"J Colloid Interface Sci"},{"key":"10.1016\/j.pharma.2024.12.002_bib0370","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.solidstatesciences.2012.01.016","article-title":"Study the effect of HLB of surfactant on particle size distribution of hematite nanoparticles prepared via the reverse microemulsion","volume":"14","author":"Housaindokht","year":"2012","journal-title":"Solid State Sci"},{"key":"10.1016\/j.pharma.2024.12.002_bib0375","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1111\/cpr.12192","article-title":"Independent effect of polymeric nanoparticle zeta potential\/surface charge, on their cytotoxicity and affinity to cells","volume":"48","author":"Shao","year":"2015","journal-title":"Cell Prolif"},{"key":"10.1016\/j.pharma.2024.12.002_bib0380","doi-asserted-by":"crossref","first-page":"216","DOI":"10.4103\/0975-1483.83765","article-title":"Formulation and evaluation of solid lipid nanoparticles of ramipril","volume":"3","author":"Ekambaram","year":"2011","journal-title":"J Young Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0385","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1208\/s12249-009-9197-2","article-title":"Diazepam-Loaded solid lipid nanoparticles: design and characterization","volume":"10","author":"Abdelbary","year":"2009","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.pharma.2024.12.002_bib0390","series-title":"An amorolfine HCl crystal and the preparation thereof","author":"Wang","year":"2011"},{"key":"10.1016\/j.pharma.2024.12.002_bib0395","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1080\/03639045.2018.1492606","article-title":"Amphotericin B-loaded solid lipid nanoparticles (SLNs) and nanostructured lipid carrier (NLCs): effect of drug loading and biopharmaceutical characterizations","volume":"44","author":"Jansook","year":"2018","journal-title":"Drug Dev Ind Pharm"},{"key":"10.1016\/j.pharma.2024.12.002_bib0400","doi-asserted-by":"crossref","first-page":"441","DOI":"10.2147\/IJN.S100625","article-title":"Miconazole-loaded solid lipid nanoparticles: formulation and evaluation of a novel formula with high bioavailability and antifungal activity","volume":"11","author":"Aljaeid","year":"2016","journal-title":"Int J Nanomedicine"}],"container-title":["Annales Pharmaceutiques Fran\u00e7aises"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003450924001743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T12:26:54Z","timestamp":1762086414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003450924001743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S0003450924001743"],"URL":"https:\/\/doi.org\/10.1016\/j.pharma.2024.12.002","relation":{},"ISSN":["0003-4509"],"issn-type":[{"value":"0003-4509","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Amorolfine hydrochloride loaded solid lipid nanoparticles: Preparation, characterization and ex vivo nail permeation study to treat onychomycosis","name":"articletitle","label":"Article Title"},{"value":"Annales Pharmaceutiques Fran\u00e7aises","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharma.2024.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Acad\u00e9mie Nationale de Pharmacie. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}